The effect of vaginal products on the basis of traditional medicine in Vaginitis

Phase 3

• Conditions: Bacterial vaginitis and Trichomoniasis.; Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere; N77.1

• Registration Number: IRCT20180217038764N2
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

patient satisfaction
Age 18-50 years
Symptoms of bacterial Vaginosis and Trichomoniasis in clinical examinations and tests

Exclusion Criteria

Recent use of anti-parasitic drugs, antibiotics, immunosuppressive drugs and vaginal drugs over the past two weeks
Intercourse and using vaginal shower for the last 48 hours
Abnormal uterine bleeding
Pregnancy and non-Lactation
Use of vaginal shower repeatedly
Smoking and alcohol consumption and coumarin anticoagulants
Multiplicity of sex partners studied
Cases of certain diseases such as liver disease, central nervous system diseases,Blood disorders, diabetes, immune deficiency and sexually transmitted diseases
having allergy to the medication compounds used in the study.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement of symptoms of bacterial vaginitis and trichomoniasis. Timepoint: First follow up 10 days after intervention, Second follow up four weeks after intervention, Third follow up three months after intervention. Method of measurement: Questionnaire, examination, test.

Secondary Outcome Measures

Name	Time	Method
Improvement of the recurrence of bacterial vaginitis and trichomoniasis. Timepoint: First follow up 10 days after intervention, Second follow up four weeks after intervention, Third follow up three months after intervention. Method of measurement: Questionnaire, examination, test.